{"id":"https://openalex.org/W2953042574","doi":"https://doi.org/10.1136/annrheumdis-2019-eular.7516","title":"FRI0206 HYDROXYCHLOROQUINE BLOOD LEVELS PREDICT RETINOPATHY IN SLE","display_name":"FRI0206 HYDROXYCHLOROQUINE BLOOD LEVELS PREDICT RETINOPATHY IN SLE","publication_year":2019,"publication_date":"2019-06-01","ids":{"openalex":"https://openalex.org/W2953042574","doi":"https://doi.org/10.1136/annrheumdis-2019-eular.7516","mag":"2953042574"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2019-eular.7516","doi":"https://doi.org/10.1136/annrheumdis-2019-eular.7516","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2019-eular.7516","pdf_url":"https://ard.bmj.com/content/annrheumdis/78/Suppl_2/782.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/78/Suppl_2/782.1.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082713013","display_name":"Michelle Petri","orcid":"https://orcid.org/0000-0003-1441-5373","observed_orcids":["https://orcid.org/0000-0003-1441-5373"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle A. Petri","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Rheumatology, Baltimore, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Rheumatology, Baltimore, United States of America","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091875362","display_name":"Jessica Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"LI Jessica","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Rheumatology, Baltimore, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Rheumatology, Baltimore, United States of America","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024449200","display_name":"Marwa Elkhalifa","orcid":"https://orcid.org/0000-0001-7838-6650","observed_orcids":["https://orcid.org/0000-0001-7838-6650"]},"institutions":[{"id":"https://openalex.org/I84524832","display_name":"Alexandria University","ror":"https://ror.org/00mzz1w90","country_code":"EG","type":"education","lineage":["https://openalex.org/I84524832"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Marwa Elkhalifa","raw_affiliation_strings":["Alexandria University, Medicine, Alexandria, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alexandria University, Medicine, Alexandria, Egypt","institution_ids":["https://openalex.org/I84524832"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030871426","display_name":"DANIEL W. GOLDMAN","orcid":"https://orcid.org/0000-0001-5003-3503","observed_orcids":["https://orcid.org/0000-0001-5003-3503","https://orcid.org/0000-0002-0013-1188"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Goldman","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Rheumatology, Baltimore, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Rheumatology, Baltimore, United States of America","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079843231","display_name":"Laurence S. Magder","orcid":"https://orcid.org/0000-0001-9297-1952","observed_orcids":["https://orcid.org/0000-0001-9297-1952"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laurence Magder","raw_affiliation_strings":["University of Maryland, Epidemiology and Public Health, Baltimore, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland, Epidemiology and Public Health, Baltimore, United States of America","institution_ids":["https://openalex.org/I126744593"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":null,"first_page":"782","last_page":"782"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13869","display_name":"Ocular and Laser Science Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hydroxychloroquine","display_name":"hydroxychloroquine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/retinopathy","display_name":"retinopathy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.984000027179718},{"id":"https://openalex.org/keywords/drug-blood-levels","display_name":"drug blood levels","score":0.7319999933242798},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6019999980926514},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.5249999761581421},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.5389999747276306},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.890999972820282},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.7279999852180481},{"id":"https://openalex.org/keywords/racial-differences","display_name":"racial differences","score":0.515999972820282},{"id":"https://openalex.org/keywords/thrombotic-risk","display_name":"thrombosis risk","score":0.6869999766349792},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.8389999866485596},{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C2779123688","wikidata":"https://www.wikidata.org/wiki/Q421094","display_name":"Hydroxychloroquine","level":5,"score":0.9606349468231201},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8949382305145264},{"id":"https://openalex.org/C2778313320","wikidata":"https://www.wikidata.org/wiki/Q550455","display_name":"Retinopathy","level":3,"score":0.7919151782989502},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.627598226070404},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5464273691177368},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.501701831817627},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4671342372894287},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4565631151199341},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.14048057794570923},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.09572353959083557},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0733216404914856},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0559486448764801},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/annrheumdis-2019-eular.7516","doi":"https://doi.org/10.1136/annrheumdis-2019-eular.7516","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2019-eular.7516","pdf_url":"https://ard.bmj.com/content/annrheumdis/78/Suppl_2/782.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2019-eular.7516","doi":"https://doi.org/10.1136/annrheumdis-2019-eular.7516","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2019-eular.7516","pdf_url":"https://ard.bmj.com/content/annrheumdis/78/Suppl_2/782.1.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320310145","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95"},{"id":"https://openalex.org/F4320319417","display_name":"Glenmark Pharmaceuticals","ror":"https://ror.org/037fhg487"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2953042574.pdf","grobid_xml":"https://content.openalex.org/works/W2953042574.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W2028426093","https://openalex.org/W2302013022"],"related_works":["https://openalex.org/W2940322432","https://openalex.org/W2973996627","https://openalex.org/W3026108945","https://openalex.org/W7131894443","https://openalex.org/W4210363836","https://openalex.org/W4303438466","https://openalex.org/W2951437693","https://openalex.org/W3166698833","https://openalex.org/W7140300892","https://openalex.org/W4309617441"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2019-06-27T00:00:00"}